SULFATRIM-SS Drug Patent Profile
✉ Email this page to a colleague
When do Sulfatrim-ss patents expire, and what generic alternatives are available?
Sulfatrim-ss is a drug marketed by Superpharm and is included in one NDA.
The generic ingredient in SULFATRIM-SS is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulfatrim-ss
A generic version of SULFATRIM-SS was approved as sulfamethoxazole; trimethoprim by SUN PHARM INDUSTRIES on August 25th, 1986.
Summary for SULFATRIM-SS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 22 |
Clinical Trials: | 4 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SULFATRIM-SS at DailyMed |
Recent Clinical Trials for SULFATRIM-SS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Roswell Park Cancer Institute | Phase 4 |
National Cancer Institute (NCI) | Phase 4 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for SULFATRIM-SS
US Patents and Regulatory Information for SULFATRIM-SS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Superpharm | SULFATRIM-SS | sulfamethoxazole; trimethoprim | TABLET;ORAL | 070065-002 | Jun 24, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |